focus
Previous article:
Drug repurposing or repositioning? The language matters
Next article: Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
Next article: Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
hotspot
focus
-
How many hemophilia patients actually want gene therapy?
2025-08-12 06:29 -
FDA advisers back CAR
2025-08-12 06:25 -
John Green on his newest strategy for fighting tuberculosis
2025-08-12 06:06 -
'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat
2025-08-12 05:24 -
President Biden's budget: Here's what you might have missed
2025-08-12 04:59 -
Readout LOUD podcast: ALS dilemma, first MASH drug, and more
2025-08-12 04:26